Quintis Ltd shares: Avoid at all costs

Quintis Ltd (ASX:QIN) updated the market yesterday, but shares remain suspended.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Embattled sandalwood grower Quintis Ltd (ASX: QIN) updated the market yesterday. The company has slashed its sales guidance and withdrew its previous earnings guidance.

Curiously, this announcement was not marked as market sensitive, although I bet that shareholders would beg to differ. Here's what management had to say:

  • The Company is unable to accurately predict the outcome of the coming sales season and so the Company is withdrawing its Cash EBITDA guidance for the year to 30 June 2017.
  • The Company now anticipates product sales in the range of $25m to $35m (down from $45m to $55m previously)
  • As at 31 May 2017, the Company's cash and cash equivalents were $17m… The Company is in on-going discussions with a number of parties with the aim of finalising a recapitalisation of the business.
  • Quintis has received non-binding equity and debt propositions from multiple parties. Discussions are on-going and no binding offer may eventuate, so Quintis has requested that its shares be kept suspended.

It's an unfortunate evolution in the saga that has smashed the value of the company's shares down 78% in a year. While the above statements speak clearly to the business' troubles, they're not the only issues that have been raised.

Management was not aware that a contract with Galderma (a key customer) has been cancelled for more than 4 months after the cancellation agreement had been signed. The Managing Director Frank Wilson also departed with zero warning 2 months ago, just before the problems with earnings became apparent.

Given all of the red flags and the additional issues revealed in yesterday's announcement, I would avoid Quintis at all costs. Even if you took the view that shares are undervalued today – and I think this would be an extremely risky view to take – the possibility of a recapitalisation could see the value of your shares vanishing.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »